Month: August 2024

With Over Four Decades of Expertise, Smith to Lead Physical Security Innovation and Enhance the Protection and Integrity of Advanced Digital InfrastructureGary SmithApplied Digital strengthens security leadership with the appointment of industry veteran Gary SmithDALLAS, Aug. 14, 2024 (GLOBE NEWSWIRE) — Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”), a designer, builder, and operator of next-generation digital infrastructure designed for High-Performance Computing (HPC) applications, today announced the appointment of Gary Smith as its new Senior Director of Physical Security. Smith has over 40 years of experience in law enforcement and corporate security and is expected to play a pivotal role in the ongoing safety and integrity of Applied Digital’s facilities. In this role, Smith will...

LAS VEGAS, Aug. 14, 2024 (GLOBE NEWSWIRE) — Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company is expecting to receive an expanded certified geological technical report by the first week of September on its 100% owned registered concession at the Bonanza Gold Mine Project located in Acaponeta, Nayarit, Mexico. The Company will continue broadening its ongoing exploration and development activities at Bonanza directed by the new guidances and recommendations contained in the upcoming second technical report. The outstanding indications revealed during the compilation process of the new report signify the potential for a substantial increase in development scope and production planning for the Bonanza property. The preliminary mineral resource estimates of gold and silver values contained...

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that Kent Kresa has decided to retire from MannKind’s Board of Directors effective September 30, 2024. In addition, the Board of Directors has appointed Steven B. Binder to the Board, also effective September 30, 2024. Kresa, who has served on MannKind’s Board of Directors since June 2004, was Chairman from 2016 until December 2020. Upon his retirement from the MannKind Board, Mr. Kresa will continue to be associated with the company in the capacity of Chairman Emeritus. Binder previously served as MannKind’s Chief Financial Officer from...

WILMETTE, Ill., Aug. 14, 2024 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients, today announced the successful dosing of the first patient in its open-label Phase 1 imaging and dosimetry clinical trial of its uPAR-targeted imaging radiopharmaceutical MNPR-101-Zr. MNPR-101-Zr was well-tolerated with no serious adverse reactions reported through the last imaging timepoint and the corresponding initial safety review. Preliminary analysis of MNPR-101-Zr’s pharmacokinetics and biodistribution suggests the low radiation dose to healthy tissue aligns with what was anticipated based on the previously presented MNPR-101-Zr preclinical biodistribution data. Dosimetry analysis showed absorbed organ doses were well below accepted...

Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immuno-oncology therapy, today reported financial results for the three and six months ended June 30, 2024. The Company also provided an update on its clinical development programs with IMNN-001, including positive topline results from the Phase 2 OVATION 2 Study in patients with advanced ovarian cancer and an update on IMNN-101, its seasonal COVID-19 booster candidate. “The second quarter and recent weeks were exciting and highly rewarding,” said Stacy Lindborg, Ph.D., president and chief executive officer of IMUNON. “Positive topline results from our Phase 2 OVATION 2 Study with IMNN-001 in advanced ovarian cancer were...

Initiated Phase 2b trial of VYN201 in nonsegmental vitiligo, with top-line results expected in mid-2025 Phase 1a SAD/MAD trial of VYN202 progressing, with data from the SAD and MAD portions expected in Q3 and Q4 2024, respectively Balance sheet expected to fund key clinical milestones for VYN201 and VYN202 through the end of 2025BRIDGEWATER, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune-mediated conditions with high unmet need, today announced financial results as of and for the three and six months ended June 30, 2024 and provided a business update. “We advanced our clinical programs in the second quarter of 2024, highlighted by the...

VANCOUVER, British Columbia, Aug. 14, 2024 (GLOBE NEWSWIRE) — via IBN – Torr Metals Inc. (“Torr” or the “Company“) (TSX-V: TMET.V) proudly announces the appointment of Mr. Gordon Maxwell, P.Geo, as a new member of the Board of Directors. Gordon is a highly distinguished B.Sc. Hon. geologist from the University of Manitoba with nearly four decades of experience across the global mining sector, holding significant leadership roles including exploration manager at Noranda Exploration and Xstrata; while most recently acting as exploration and business development manager at Glencore. His contributions to the Canadian mining industry have earned him prestigious industry accolades, including the David Barr Award from AME (Association for Mineral Exploration) BC for Health and Safety in 2012 and the PDAC (Prospectors...

Applauds first FDA approval of non-injection-based epinephrine device Reiterates expected timing for filing of New Drug Application (NDA) for Anaphylm™ (epinephrine) Sublingual Film to the FDA in the first quarter of 2025WARREN, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, today commented on the approval of a non-injection-based device for delivery of epinephrine for the treatment of severe allergic reactions, including anaphylaxis, by the United States Food and Drug Administration (FDA). “Use of epinephrine for the treatment of severe allergic reactions, including anaphylaxis, has been in needle-based...

NEW YORK, N.Y., Aug. 14, 2024 (GLOBE NEWSWIRE) — JetBlue Airways Corporation (NASDAQ: JBLU) (“JetBlue”) today announced that JetBlue and JetBlue Loyalty, LP (the “Loyalty LP” and, together with JetBlue, the “Issuers”), a newly formed Cayman Islands exempted limited partnership and an indirect wholly-owned subsidiary of JetBlue, priced their (1) $2,000 million aggregate principal amount of 9.875% senior secured notes due 2031 (the “Notes”) and (2) $765 million senior secured Term Loan B due 2029 (the “Term Loan” and, together with the Notes, the “Loyalty Financings”). The Notes offering was increased by $500 million from the previously announced offering size of $1,500 million in connection with a decrease to the size of the Term Loan. JetBlue expects to close the Loyalty Financings on or about August 27, 2024, subject to the satisfaction...

On August 15, Terranet AB (publ) will release its Q2 report for 2024. On the same day at 10 a.m. CET, the company’s CEO Magnus Andersson and CTO Pierre Ekwall will provide an update on the operations in a webcast. The event will be broadcasted digitally and is open to the public. The presentation will be held in English. Via the webcast, there is an opportunity to ask written questions. Link to the webcast: https://ir.financialhearings.com/terranet-report-2024 The webcast will be available on both Finwire’s and Terranet’s websites after the broadcast has finished. For more information, please contactMagnus Andersson CEO Email: magnus.andersson@terranet.se About Terranet AB (publ)  Terranet is on a mission to save lives in urban traffic.  We develop breakthrough tech solutions for Advanced Driver Assistance Systems (ADAS) and Autonomous...